Mobidiag raises 3.99 Million Euros in a crowdfunding campaign on Kansalaisrahoitus.

Mobidiag Ltd., an Espoo, Finland-based molecular diagnostics company, announced that it has successfully completed a 3,99 million euros funding via the Finnish investment service company Kansalaisrahoitus Oy.

The money comes from about 300 investors and represent an addition to a 15M euros loan received from European Investment Bank in 2016. The funding will be used for expanding the company' sales and marketing channels in Europe and other parts of the world.

Mobidiag, founded in 2000 and led by CEO Tuomas Tenkanen, provides innovative solutions for in vitro diagnostics of infectious diseases. More reliable and faster diagnostics can ensure patient care and safety by detecting infection type allowing selection of the appropriate treatment with or without antibiotics. Mobidiag has used its expertise in the detection of gastrointestinal infections and multi-drug resistant organisms, also known as superbugs.